Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio EPS Diluted (Quarterly) : -0.1191 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.1191 |
| June 30, 2026 | -0.1802 |
| March 31, 2026 | 0.0143 |
| December 31, 2025 | -0.1063 |
| September 30, 2025 | -0.163 |
| June 30, 2025 | -0.1732 |
| March 31, 2025 | -0.1572 |
| December 31, 2024 | -0.1468 |
| September 30, 2024 | -0.1506 |
| June 30, 2024 | -1.890 |
| March 31, 2024 | -0.0675 |
| December 31, 2023 | -0.063 |
| September 30, 2023 | -0.0898 |
| June 30, 2023 | -0.0943 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.0993 |
| December 31, 2022 | -0.0954 |
| September 30, 2022 | -0.1246 |
| June 30, 2022 | -0.1609 |
| March 31, 2022 | -0.0998 |
| December 31, 2021 | -0.1196 |
| September 30, 2021 | -0.1061 |
| June 30, 2021 | -0.0948 |
| March 31, 2021 | -0.1202 |
| December 31, 2020 | -0.1074 |
| September 30, 2020 | -0.0955 |
| June 30, 2020 | -0.4659 |
| March 31, 2020 | -0.4739 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.5637 |
| Johnson & Johnson | 0.0858 |
| Merck & Co., Inc. | 2.044 |
| Bristol Myers Squibb Co. | 1.053 |
| ANI Pharmaceuticals, Inc. | 1.510 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.90M |
| Revenue (Quarterly) | 44.95M |
| Total Expenses (Quarterly) | 86.85M |
| Enterprise Value | 1.213B |
| Gross Profit Margin (Quarterly) | 72.18% |
| Profit Margin (Quarterly) | -93.21% |
| Earnings Yield | -9.81% |
| Normalized Earnings Yield | -9.404 |